Gossamer Bio, Inc. (GOSS) vs Pliant Therapeutics, Inc. (PLRX)
A side-by-side comparison of Gossamer Bio, Inc. and Pliant Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOSS
Gossamer Bio, Inc.
$10.55HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
PLRX
Pliant Therapeutics, Inc.
$1.02HealthcareDelayed quote: Oct 6, 2026, 1:52 PM EDT
Total return — GOSS vs PLRX
growth of $100 · dividends reinvested · last 6yGOSS -98.9% (-52.7%/yr)PLRX -95.2% (-39.6%/yr)PLRX compounded faster over this window
GOSS PLRX
GOSS vs PLRX: by the numbers
- •GOSS is the larger company ($64M vs $63M market cap).
- •Both run net losses; PLRX's is the smaller (0.00% vs -235.00% net margin).
Metrics side by side
Valuation
| Metric | GOSS | PLRX |
|---|---|---|
| P/S ratio | 1.21 | N/A |
| P/B ratio | N/A | 0.43 |
Profitability
| Metric | GOSS | PLRX |
|---|---|---|
| Gross margin | 99.56% | 0.00% |
| Operating margin | -336.81% | 0.00% |
| Net margin | -235.00% | 0.00% |
| ROE | N/A | -62.81% |
| ROIC | N/A | -56.22% |
Growth (annualized)
| Metric | GOSS | PLRX |
|---|---|---|
| Total return CAGR (5Y) | -59.51% | -43.17% |
Frequently asked
- How have GOSS and PLRX total returns compared?
- Over the past 5 years, GOSS delivered -59.51% and PLRX delivered -43.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.